APO Research
Talk to an analyst

APO RESEARCH · REPORT

Orally Disintegrating Tablet

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.

Selected research

Industry Growth & Trends

Global Orally Disintegrating Tablet Industry Growth and Trends Forecast to 2032

26 December 2025108 pages

Choose your research edition.

Industry ResearchOrally Disintegrating Tablet Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Orally Disintegrating Tablet Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Orally Disintegrating Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Orally Disintegrating Tablet Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Orally Disintegrating Tablet Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.

Global Orally Disintegrating Tablet main manufactuers include Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb and Conquer, totally accounting for about 17% of the market. North America is the largest market of glass packaging, holding a share more than 40%. As for the types of products, it can be divided into anti-psychotics drug, anti-epileptics drug and others. As for the applications of products, it is widely used in CNS diseases, gastrointestinal diseases, CVS diseases and others. The most common application is in CNS diseases packaging, with a share about 55%.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Orally Disintegrating Tablet market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Orally Disintegrating Tablet market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Orally Disintegrating Tablet market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Orally Disintegrating Tablet.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Orally Disintegrating Tablet market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Orally Disintegrating Tablet Market by Company

Teva

Merck

Mylan

Pfizer

Johnson and Johnson

GSK

Otsuka

Eli Lilly and Company

AstraZeneca

Bristol-Myers Squibb

Conquer

Orally Disintegrating Tablet Segment by Type

Anti-Psychotics Drug

Anti-Epileptics Drug

Others

Orally Disintegrating Tablet Segment by Application

CNS Diseases

Gastrointestinal Diseases

CVS Diseases

Others

Orally Disintegrating Tablet Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orally Disintegrating Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Orally Disintegrating Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Orally Disintegrating Tablet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Orally Disintegrating Tablet manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Orally Disintegrating Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Anti-Psychotics Drug Table 2. Major Company of Anti-Epileptics Drug Table 3. Major Company of Others Table 4. Global Orally Disintegrating Tablet Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Orally Disintegrating Tablet Sales by Type (2021-2026) & (M Units) Table 6. Global Orally Disintegrating Tablet Sales Market Share in Volume by Type (2021-2026) Table 7. Global Orally Disintegrating Tablet Sales by Type (2021-2026) & (US$ Million) Table 8. Global Orally Disintegrating Tablet Sales Market Share in Value by Type (2021-2026) Table 9. Global Orally Disintegrating Tablet Price by Type (2021-2026) & (US$/Unit) Table 10. Global Orally Disintegrating Tablet Sales by Type (2027-2032) & (M Units) Table 11. Global Orally Disintegrating Tablet Sales Market Share in Volume by Type (2027-2032) Table 12. Global Orally Disintegrating Tablet Sales by Type (2027-2032) & (US$ Million) Table 13. Global Orally Disintegrating Tablet Sales Market Share in Value by Type (2027-2032) Table 14. Global Orally Disintegrating Tablet Price by Type (2027-2032) & (US$/Unit) Table 15. North America Orally Disintegrating Tablet Sales by Type (2021-2026) & (M Units) Table 16. North America Orally Disintegrating Tablet Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Orally Disintegrating Tablet Sales by Type (2021-2026) & (M Units) Table 18. Europe Orally Disintegrating Tablet Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Orally Disintegrating Tablet Sales by Type (2021-2026) & (M Units) Table 20. Asia-Pacific Orally Disintegrating Tablet Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Orally Disintegrating Tablet Sales by Type (2021-2026) & (M Units) Table 22. Latin America Orally Disintegrating Tablet Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Orally Disintegrating Tablet Sales by Type (2021-2026) & (M Units) Table 24. Middle East and Africa Orally Disintegrating Tablet Sales by Type (2021-2026) & (US$ Million) Table 25. Orally Disintegrating Tablet Industry Trends Table 26. Orally Disintegrating Tablet Industry Drivers Table 27. Orally Disintegrating Tablet Industry Opportunities and Challenges Table 28. Orally Disintegrating Tablet Industry Restraints Table 29. Global Orally Disintegrating Tablet Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Orally Disintegrating Tablet Revenue Market Share by Company (2021-2026) Table 31. Global Orally Disintegrating Tablet Sales by Company (2021-2026) & (M Units) Table 32. Global Orally Disintegrating Tablet Sales Share by Company (2021-2026) Table 33. Global Orally Disintegrating Tablet Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Orally Disintegrating Tablet Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Orally Disintegrating Tablet Major Company Production Sites and Headquarters Table 36. Global Orally Disintegrating Tablet Company, Product Type & Application Table 37. Global Orally Disintegrating Tablet Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Orally Disintegrating Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Orally Disintegrating Tablet Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Orally Disintegrating Tablet Sales by Region (2021-2026) & (M Units) Table 42. Global Orally Disintegrating Tablet Sales Market Share in Volume by Region (2021-2026) Table 43. Global Orally Disintegrating Tablet Sales by Region (2021-2026) & (US$ Million) Table 44. Global Orally Disintegrating Tablet Sales Market Share in Value by Region (2021-2026) Table 45. Global Orally Disintegrating Tablet Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Orally Disintegrating Tablet Sales by Region (2027-2032) & (M Units) Table 47. Global Orally Disintegrating Tablet Sales Market Share in Volume by Region (2027-2032) Table 48. Global Orally Disintegrating Tablet Sales by Region (2027-2032) & (US$ Million) Table 49. Global Orally Disintegrating Tablet Sales Market Share in Value by Region (2027-2032) Table 50. Global Orally Disintegrating Tablet Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Orally Disintegrating Tablet Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Orally Disintegrating Tablet Sales by Application (2021-2026) & (M Units) Table 53. Global Orally Disintegrating Tablet Sales Market Share in Volume by Application (2021-2026) Table 54. Global Orally Disintegrating Tablet Sales by Application (2021-2026) & (US$ Million) Table 55. Global Orally Disintegrating Tablet Sales Market Share in Value by Application (2021-2026) Table 56. Global Orally Disintegrating Tablet Price by Application (2021-2026) & (US$/Unit) Table 57. Global Orally Disintegrating Tablet Sales by Application (2027-2032) & (M Units) Table 58. Global Orally Disintegrating Tablet Sales Market Share in Volume by Application (2027-2032) Table 59. Global Orally Disintegrating Tablet Sales by Application (2027-2032) & (US$ Million) Table 60. Global Orally Disintegrating Tablet Sales Market Share in Value by Application (2027-2032) Table 61. Global Orally Disintegrating Tablet Price by Application (2027-2032) & (US$/Unit) Table 62. North America Orally Disintegrating Tablet Sales by Application (2021-2026) & (M Units) Table 63. North America Orally Disintegrating Tablet Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Orally Disintegrating Tablet Sales by Application (2021-2026) & (M Units) Table 65. Europe Orally Disintegrating Tablet Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Orally Disintegrating Tablet Sales by Application (2021-2026) & (M Units) Table 67. Asia-Pacific Orally Disintegrating Tablet Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Orally Disintegrating Tablet Sales by Application (2021-2026) & (M Units) Table 69. Latin America Orally Disintegrating Tablet Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Orally Disintegrating Tablet Sales by Application (2021-2026) & (M Units) Table 71. Middle East and Africa Orally Disintegrating Tablet Sales by Application (2021-2026) & (US$ Million) Table 72. Teva Company Information Table 73. Teva Business Overview Table 74. Teva Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Teva Orally Disintegrating Tablet Product Portfolio Table 76. Teva Recent Development Table 77. Merck Company Information Table 78. Merck Business Overview Table 79. Merck Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Merck Orally Disintegrating Tablet Product Portfolio Table 81. Merck Recent Development Table 82. Mylan Company Information Table 83. Mylan Business Overview Table 84. Mylan Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Mylan Orally Disintegrating Tablet Product Portfolio Table 86. Mylan Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Pfizer Orally Disintegrating Tablet Product Portfolio Table 91. Pfizer Recent Development Table 92. Johnson and Johnson Company Information Table 93. Johnson and Johnson Business Overview Table 94. Johnson and Johnson Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Johnson and Johnson Orally Disintegrating Tablet Product Portfolio Table 96. Johnson and Johnson Recent Development Table 97. GSK Company Information Table 98. GSK Business Overview Table 99. GSK Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. GSK Orally Disintegrating Tablet Product Portfolio Table 101. GSK Recent Development Table 102. Otsuka Company Information Table 103. Otsuka Business Overview Table 104. Otsuka Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Otsuka Orally Disintegrating Tablet Product Portfolio Table 106. Otsuka Recent Development Table 107. Eli Lilly and Company Company Information Table 108. Eli Lilly and Company Business Overview Table 109. Eli Lilly and Company Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Eli Lilly and Company Orally Disintegrating Tablet Product Portfolio Table 111. Eli Lilly and Company Recent Development Table 112. AstraZeneca Company Information Table 113. AstraZeneca Business Overview Table 114. AstraZeneca Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. AstraZeneca Orally Disintegrating Tablet Product Portfolio Table 116. AstraZeneca Recent Development Table 117. Bristol-Myers Squibb Company Information Table 118. Bristol-Myers Squibb Business Overview Table 119. Bristol-Myers Squibb Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Bristol-Myers Squibb Orally Disintegrating Tablet Product Portfolio Table 121. Bristol-Myers Squibb Recent Development Table 122. Conquer Company Information Table 123. Conquer Business Overview Table 124. Conquer Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Conquer Orally Disintegrating Tablet Product Portfolio Table 126. Conquer Recent Development Table 127. North America Orally Disintegrating Tablet Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 128. North America Orally Disintegrating Tablet Sales by Country (2021-2026) & (M Units) Table 129. North America Orally Disintegrating Tablet Sales Market Share by Country (2021-2026) Table 130. North America Orally Disintegrating Tablet Sales Forecast by Country (2027-2032) & (M Units) Table 131. North America Orally Disintegrating Tablet Sales Market Share Forecast by Country (2027-2032) Table 132. North America Orally Disintegrating Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Orally Disintegrating Tablet Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Orally Disintegrating Tablet Market Share by Country (2021-2026) Table 135. North America Orally Disintegrating Tablet Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Orally Disintegrating Tablet Market Share Forecast by Country (2027-2032) Table 137. Europe Orally Disintegrating Tablet Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 138. Europe Orally Disintegrating Tablet Sales by Country (2021-2026) & (M Units) Table 139. Europe Orally Disintegrating Tablet Sales Market Share by Country (2021-2026) Table 140. Europe Orally Disintegrating Tablet Sales Forecast by Country (2027-2032) & (M Units) Table 141. Europe Orally Disintegrating Tablet Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Orally Disintegrating Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Orally Disintegrating Tablet Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Orally Disintegrating Tablet Market Share by Country (2021-2026) Table 145. Europe Orally Disintegrating Tablet Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Orally Disintegrating Tablet Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Orally Disintegrating Tablet Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Orally Disintegrating Tablet Sales by Country (2021-2026) & (M Units) Table 149. Asia-Pacific Orally Disintegrating Tablet Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Orally Disintegrating Tablet Sales Forecast by Country (2027-2032) & (M Units) Table 151. Asia-Pacific Orally Disintegrating Tablet Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Orally Disintegrating Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Orally Disintegrating Tablet Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Orally Disintegrating Tablet Market Share by Country (2021-2026) Table 155. Asia-Pacific Orally Disintegrating Tablet Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Orally Disintegrating Tablet Market Share Forecast by Country (2027-2032) Table 157. Latin America Orally Disintegrating Tablet Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 158. Latin America Orally Disintegrating Tablet Sales by Country (2021-2026) & (M Units) Table 159. Latin America Orally Disintegrating Tablet Sales Market Share by Country (2021-2026) Table 160. Latin America Orally Disintegrating Tablet Sales Forecast by Country (2027-2032) & (M Units) Table 161. Latin America Orally Disintegrating Tablet Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Orally Disintegrating Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Orally Disintegrating Tablet Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Orally Disintegrating Tablet Market Share by Country (2021-2026) Table 165. Latin America Orally Disintegrating Tablet Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Orally Disintegrating Tablet Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Orally Disintegrating Tablet Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Orally Disintegrating Tablet Sales by Country (2021-2026) & (M Units) Table 169. Middle East and Africa Orally Disintegrating Tablet Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Orally Disintegrating Tablet Sales Forecast by Country (2027-2032) & (M Units) Table 171. Middle East and Africa Orally Disintegrating Tablet Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Orally Disintegrating Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Orally Disintegrating Tablet Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Orally Disintegrating Tablet Market Share by Country (2021-2026) Table 175. Middle East and Africa Orally Disintegrating Tablet Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Orally Disintegrating Tablet Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Orally Disintegrating Tablet Distributors List Table 180. Orally Disintegrating Tablet Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Orally Disintegrating Tablet Image Figure 2. Global Orally Disintegrating Tablet Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Orally Disintegrating Tablet Market Size (2021-2032) & (US$ Million) Figure 4. Global Orally Disintegrating Tablet Sales (2021-2032) & (M Units) Figure 5. Anti-Psychotics Drug Image Figure 6. Global Anti-Psychotics Drug Sales YoY Growth (2021-2032) & (M Units) Figure 7. Anti-Epileptics Drug Image Figure 8. Global Anti-Epileptics Drug Sales YoY Growth (2021-2032) & (M Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (M Units) Figure 11. Global Orally Disintegrating Tablet Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Orally Disintegrating Tablet Market Share by Type 2025 VS 2032 Figure 13. North America Orally Disintegrating Tablet Sales Market Share in Volume by Type in 2025 Figure 14. North America Orally Disintegrating Tablet Sales Market Share in Value by Type in 2025 Figure 15. Europe Orally Disintegrating Tablet Sales Market Share in Volume by Type in 2025 Figure 16. Europe Orally Disintegrating Tablet Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Orally Disintegrating Tablet Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Orally Disintegrating Tablet Sales Market Share in Value by Type in 2025 Figure 19. Latin America Orally Disintegrating Tablet Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Orally Disintegrating Tablet Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Orally Disintegrating Tablet Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Orally Disintegrating Tablet Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Orally Disintegrating Tablet Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. CNS Diseases Image Figure 26. Global CNS Diseases Sales YoY Growth (2021-2032) & (M Units) Figure 27. Gastrointestinal Diseases Image Figure 28. Global Gastrointestinal Diseases Sales YoY Growth (2021-2032) & (M Units) Figure 29. CVS Diseases Image Figure 30. Global CVS Diseases Sales YoY Growth (2021-2032) & (M Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (M Units) Figure 33. Global Orally Disintegrating Tablet Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Orally Disintegrating Tablet Market Share by Application 2025 VS 2032 Figure 35. North America Orally Disintegrating Tablet Sales Market Share in Volume by Application in 2025 Figure 36. North America Orally Disintegrating Tablet Sales Market Share in Value by Application in 2025 Figure 37. Europe Orally Disintegrating Tablet Sales Market Share in Volume by Application in 2025 Figure 38. Europe Orally Disintegrating Tablet Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Orally Disintegrating Tablet Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Orally Disintegrating Tablet Sales Market Share in Value by Application in 2025 Figure 41. Latin America Orally Disintegrating Tablet Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Orally Disintegrating Tablet Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Orally Disintegrating Tablet Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Orally Disintegrating Tablet Sales Market Share in Value by Application in 2025 Figure 45. North America Orally Disintegrating Tablet Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 46. North America Orally Disintegrating Tablet Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Orally Disintegrating Tablet Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Orally Disintegrating Tablet Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Orally Disintegrating Tablet Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 50. Europe Orally Disintegrating Tablet Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Orally Disintegrating Tablet Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Orally Disintegrating Tablet Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Orally Disintegrating Tablet Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 54. Asia-Pacific Orally Disintegrating Tablet Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Orally Disintegrating Tablet Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Orally Disintegrating Tablet Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Orally Disintegrating Tablet Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 58. Latin America Orally Disintegrating Tablet Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Orally Disintegrating Tablet Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Orally Disintegrating Tablet Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Orally Disintegrating Tablet Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 62. Middle East and Africa Orally Disintegrating Tablet Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Orally Disintegrating Tablet Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Orally Disintegrating Tablet Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Orally Disintegrating Tablet Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Orally Disintegrating Tablet Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Anti-Psychotics Drug
  • Anti-Epileptics Drug
  • Others
Applications
  • CNS Diseases
  • Gastrointestinal Diseases
  • CVS Diseases
  • Others
Companies covered
  • Teva
  • Merck
  • Mylan
  • Pfizer
  • Johnson and Johnson
  • GSK
  • Otsuka
  • Eli Lilly and Company
  • AstraZeneca
  • Bristol-Myers Squibb
  • Conquer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Orally Disintegrating Tablet Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Orally Disintegrating Tablet Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Orally Disintegrating Tablet Market by Type
  6. 1.3.1 Anti-Psychotics Drug
  7. 1.3.2 Anti-Epileptics Drug
  8. 1.3.3 Others
  9. 1.4 Global Orally Disintegrating Tablet Market Size by Type
  10. 1.4.1 Global Orally Disintegrating Tablet Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Orally Disintegrating Tablet Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Orally Disintegrating Tablet Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Orally Disintegrating Tablet Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Orally Disintegrating Tablet Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Orally Disintegrating Tablet Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Orally Disintegrating Tablet Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Orally Disintegrating Tablet Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Orally Disintegrating Tablet Industry Trends
  2. 2.2 Orally Disintegrating Tablet Industry Drivers
  3. 2.3 Orally Disintegrating Tablet Industry Opportunities and Challenges
  4. 2.4 Orally Disintegrating Tablet Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Orally Disintegrating Tablet Revenue (2021-2026)
  2. 3.2 Global Top Players by Orally Disintegrating Tablet Sales (2021-2026)
  3. 3.3 Global Top Players by Orally Disintegrating Tablet Price (2021-2026)
  4. 3.4 Global Orally Disintegrating Tablet Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Orally Disintegrating Tablet Major Company Production Sites & Headquarters
  6. 3.6 Global Orally Disintegrating Tablet Company, Product Type & Application
  7. 3.7 Global Orally Disintegrating Tablet Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Orally Disintegrating Tablet Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Orally Disintegrating Tablet Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Orally Disintegrating Tablet Tier 1, Tier 2, and Tier 3
4 Orally Disintegrating Tablet Regional Status and Outlook
  1. 4.1 Global Orally Disintegrating Tablet Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Orally Disintegrating Tablet Historic Market Size by Region
  3. 4.2.1 Global Orally Disintegrating Tablet Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Orally Disintegrating Tablet Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Orally Disintegrating Tablet Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Orally Disintegrating Tablet Forecasted Market Size by Region
  7. 4.3.1 Global Orally Disintegrating Tablet Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Orally Disintegrating Tablet Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Orally Disintegrating Tablet Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Orally Disintegrating Tablet by Application
  1. 5.1 Orally Disintegrating Tablet Market by Application
  2. 5.1.1 CNS Diseases
  3. 5.1.2 Gastrointestinal Diseases
  4. 5.1.3 CVS Diseases
  5. 5.1.4 Others
  6. 5.2 Global Orally Disintegrating Tablet Market Size by Application
  7. 5.2.1 Global Orally Disintegrating Tablet Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Orally Disintegrating Tablet Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Orally Disintegrating Tablet Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Orally Disintegrating Tablet Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Orally Disintegrating Tablet Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Orally Disintegrating Tablet Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Orally Disintegrating Tablet Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Orally Disintegrating Tablet Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Orally Disintegrating Tablet Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Orally Disintegrating Tablet Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Mylan
  14. 6.3.1 Mylan Company Information
  15. 6.3.2 Mylan Business Overview
  16. 6.3.3 Mylan Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Orally Disintegrating Tablet Product Portfolio
  18. 6.3.5 Mylan Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Orally Disintegrating Tablet Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Johnson and Johnson
  26. 6.5.1 Johnson and Johnson Company Information
  27. 6.5.2 Johnson and Johnson Business Overview
  28. 6.5.3 Johnson and Johnson Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Johnson and Johnson Orally Disintegrating Tablet Product Portfolio
  30. 6.5.5 Johnson and Johnson Recent Developments
  31. 6.6 GSK
  32. 6.6.1 GSK Company Information
  33. 6.6.2 GSK Business Overview
  34. 6.6.3 GSK Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GSK Orally Disintegrating Tablet Product Portfolio
  36. 6.6.5 GSK Recent Developments
  37. 6.7 Otsuka
  38. 6.7.1 Otsuka Company Information
  39. 6.7.2 Otsuka Business Overview
  40. 6.7.3 Otsuka Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Otsuka Orally Disintegrating Tablet Product Portfolio
  42. 6.7.5 Otsuka Recent Developments
  43. 6.8 Eli Lilly and Company
  44. 6.8.1 Eli Lilly and Company Company Information
  45. 6.8.2 Eli Lilly and Company Business Overview
  46. 6.8.3 Eli Lilly and Company Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Eli Lilly and Company Orally Disintegrating Tablet Product Portfolio
  48. 6.8.5 Eli Lilly and Company Recent Developments
  49. 6.9 AstraZeneca
  50. 6.9.1 AstraZeneca Company Information
  51. 6.9.2 AstraZeneca Business Overview
  52. 6.9.3 AstraZeneca Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 AstraZeneca Orally Disintegrating Tablet Product Portfolio
  54. 6.9.5 AstraZeneca Recent Developments
  55. 6.10 Bristol-Myers Squibb
  56. 6.10.1 Bristol-Myers Squibb Company Information
  57. 6.10.2 Bristol-Myers Squibb Business Overview
  58. 6.10.3 Bristol-Myers Squibb Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Bristol-Myers Squibb Orally Disintegrating Tablet Product Portfolio
  60. 6.10.5 Bristol-Myers Squibb Recent Developments
  61. 6.11 Conquer
  62. 6.11.1 Conquer Company Information
  63. 6.11.2 Conquer Business Overview
  64. 6.11.3 Conquer Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Conquer Orally Disintegrating Tablet Product Portfolio
  66. 6.11.5 Conquer Recent Developments
7 North America by Country
  1. 7.1 North America Orally Disintegrating Tablet Sales by Country
  2. 7.1.1 North America Orally Disintegrating Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Orally Disintegrating Tablet Sales by Country (2021-2026)
  4. 7.1.3 North America Orally Disintegrating Tablet Sales Forecast by Country (2027-2032)
  5. 7.2 North America Orally Disintegrating Tablet Market Size by Country
  6. 7.2.1 North America Orally Disintegrating Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Orally Disintegrating Tablet Market Size by Country (2021-2026)
  8. 7.2.3 North America Orally Disintegrating Tablet Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Orally Disintegrating Tablet Sales by Country
  2. 8.1.1 Europe Orally Disintegrating Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Orally Disintegrating Tablet Sales by Country (2021-2026)
  4. 8.1.3 Europe Orally Disintegrating Tablet Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Orally Disintegrating Tablet Market Size by Country
  6. 8.2.1 Europe Orally Disintegrating Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Orally Disintegrating Tablet Market Size by Country (2021-2026)
  8. 8.2.3 Europe Orally Disintegrating Tablet Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Orally Disintegrating Tablet Sales by Country
  2. 9.1.1 Asia-Pacific Orally Disintegrating Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Orally Disintegrating Tablet Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Orally Disintegrating Tablet Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Orally Disintegrating Tablet Market Size by Country
  6. 9.2.1 Asia-Pacific Orally Disintegrating Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Orally Disintegrating Tablet Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Orally Disintegrating Tablet Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Orally Disintegrating Tablet Sales by Country
  2. 10.1.1 South America Orally Disintegrating Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Orally Disintegrating Tablet Sales by Country (2021-2026)
  4. 10.1.3 South America Orally Disintegrating Tablet Sales Forecast by Country (2027-2032)
  5. 10.2 South America Orally Disintegrating Tablet Market Size by Country
  6. 10.2.1 South America Orally Disintegrating Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Orally Disintegrating Tablet Market Size by Country (2021-2026)
  8. 10.2.3 South America Orally Disintegrating Tablet Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Orally Disintegrating Tablet Sales by Country
  2. 11.1.1 Middle East and Africa Orally Disintegrating Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Orally Disintegrating Tablet Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Orally Disintegrating Tablet Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Orally Disintegrating Tablet Market Size by Country
  6. 11.2.1 Middle East and Africa Orally Disintegrating Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Orally Disintegrating Tablet Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Orally Disintegrating Tablet Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Orally Disintegrating Tablet Value Chain Analysis
  2. 12.1.1 Orally Disintegrating Tablet Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Orally Disintegrating Tablet Production Mode & Process
  7. 12.2 Orally Disintegrating Tablet Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Orally Disintegrating Tablet Distributors
  10. 12.2.3 Orally Disintegrating Tablet Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst